Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Note the dates!

$Annexon (ANNX.US)$ Key Anticipated Milestones for Flagship Programs
*ANX005 in GBS: Initial topline data from RWE comparability protocol with IGOS now expected by year-end 2024 to support a planned BLA submission in the first half of 2025
*ANX1502 in CAD: POC trial evaluating the pharmacodynamics and efficacy of an oral tablet formulation in CAD anticipated to provide initial data in the fourth quarter of 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
1
+0
4
Translate
Report
5657 Views
Comment
Sign in to post a comment
3568Followers
23Following
53KVisitors
Follow